#1 Clinical Trials Search in Europe

Clindamycin Phosphate

Clindamycin Phosphate is an antibiotic medication that has been the subject of several clinical trials to evaluate its effectiveness in treating various medical conditions. These trials aim to assess the drug’s safety and efficacy in different formulations and combinations, as well as its potential to address specific health concerns. This article will provide an overview of the recent clinical trials involving Clindamycin Phosphate and their findings.

Table of Contents

What is Clindamycin Phosphate?

Clindamycin Phosphate is an antibiotic medication used to treat various bacterial infections. It belongs to a class of drugs called lincosamide antibiotics[1]. This medication works by stopping the growth of bacteria, helping your body’s immune system fight off the infection.

Clindamycin Phosphate is known by several other names, including[1]:

  • Clindamycin hydrochloride (when given as oral capsules)
  • Clindamycin palmitate (when given as an oral solution)

Medical Uses

Clindamycin Phosphate is used to treat a variety of bacterial infections, including[1][2][3]:

  • Bacterial infections: General bacterial infections in various parts of the body.
  • Osteoarticular infections (OAI): These are infections in bones and joints, often caused by bacteria like Staphylococcus aureus.
  • Bacterial vaginosis (BV): An infection of the vagina caused by an overgrowth of certain bacteria.
  • Acne: Clindamycin is often used topically (applied to the skin) to treat acne.

How is it Administered?

Clindamycin Phosphate can be administered in several ways, depending on the condition being treated[1][4][5]:

  • Intravenous (IV): Given directly into a vein, usually for more severe infections.
  • Oral capsules or solution: Taken by mouth for various infections.
  • Topical: Applied directly to the skin, often used for acne treatment.
  • Vaginal cream: Used for treating bacterial vaginosis.

The dosage and duration of treatment can vary depending on the type and severity of the infection, as well as the patient’s age and weight. For example, in one study, children received 30-40 mg/kg/day of IV clindamycin, divided into doses given every 6 or 8 hours[1].

Effectiveness and Research

Several clinical trials have been conducted to study the effectiveness of Clindamycin Phosphate in various conditions:

  • Osteoarticular infections: A study called the CLINDOS trial investigated the use of clindamycin in combination with either rifampin or levofloxacin for treating bone and joint infections caused by Staphylococcus aureus[2].
  • Bacterial vaginosis in pregnancy: Research has been conducted to see if treating bacterial vaginosis with clindamycin in early pregnancy could reduce the risk of preterm delivery[3].
  • Acne treatment: Studies have looked at the effectiveness of clindamycin, often in combination with other medications like adapalene, for treating acne[5].

Potential Side Effects

Like all medications, Clindamycin Phosphate can cause side effects. Some potential side effects include[6]:

  • Skin-related side effects: When used topically or in combination with certain treatments (like Tumor Treating Fields for brain tumors), clindamycin may cause skin irritation or rashes.
  • Gastrointestinal issues: When taken orally, clindamycin can sometimes cause stomach upset, diarrhea, or other digestive problems.

It’s important to discuss potential side effects with your healthcare provider before starting treatment.

Special Considerations

There are some special considerations to keep in mind when using Clindamycin Phosphate:

  • Pregnancy: Some studies have looked at the use of clindamycin in pregnant women, particularly for treating bacterial vaginosis. Always consult with your healthcare provider about the risks and benefits of using any medication during pregnancy[3].
  • Children and obesity: Research has been conducted to understand how clindamycin works in children with higher body mass index (BMI). This helps determine if dosing should be adjusted for overweight or obese children[1].
  • Combination therapy: Clindamycin is often used in combination with other medications. For example, it may be combined with adapalene for acne treatment or with other antibiotics for certain infections[5][2].
Condition Formulation Key Findings/Objectives
Bacterial Vaginosis in Pregnancy Vaginal cream Investigating effect on preterm delivery rates
Acne Vulgaris Topical lotion Assessing efficacy in reducing acne lesions
Glioblastoma (skin side effects) Topical lotion with Triamcinolone Evaluating prevention of skin toxicity from TTFields
Vaginal Infections Vaginal product Comparing efficacy with other treatments
Pediatric Infections (obese patients) Intravenous and oral Studying pharmacokinetics in overweight children

FAQ

  • What conditions are being studied using Clindamycin Phosphate in clinical trials? Clinical trials are exploring the use of Clindamycin Phosphate for various conditions, including bacterial vaginosis in pregnant women, acne vulgaris, skin-related side effects of tumor treating fields in glioblastoma patients, and vaginal infections.
  • How is Clindamycin Phosphate being administered in these trials? Clindamycin Phosphate is being administered in different forms depending on the condition being treated. For example, it's used as a vaginal cream for bacterial vaginosis, as a topical lotion for acne, and as an intravenous or oral medication for certain infections.
  • Are there any combination therapies being tested with Clindamycin Phosphate? Yes, some trials are testing Clindamycin Phosphate in combination with other medications. For instance, it's being studied in combination with Adapalene for acne treatment and with Triamcinolone for preventing skin-related side effects in glioblastoma patients undergoing tumor treating fields therapy.
  • What are some of the primary outcomes being measured in these trials? The primary outcomes vary depending on the condition being studied. They include reduction in preterm delivery rates for bacterial vaginosis, decrease in acne lesions for acne vulgaris, prevention of skin toxicity in glioblastoma patients, and resolution of clinical symptoms for vaginal infections.
  • Are there any special populations being studied in these Clindamycin Phosphate trials? Yes, some trials are focusing on specific populations. For example, one study is examining the use of Clindamycin Phosphate in pregnant women with bacterial vaginosis. Another study is looking at its pharmacokinetics in overweight and obese children.

Ongoing Clinical Trials on Clindamycin Phosphate

  • A study comparing furazidin and clindamycin for women with bacterial vaginosis

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Italy Poland Slovakia

  • Antibiotic Treatment with Clindamycin and Benzylpenicillin to Prevent Group G and C Streptococcal Infections in Pregnant Women

    Recruiting

    1 1 1 1
    Investigated drugs:
    Finland

  • Early Saline Pleural Irrigation for Patients with Complicated Pleural Infections

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Clindamycin Use for Infection Prevention in Pregnant Women Undergoing Maternal or Fetal Surgery

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Belgium

Glossary

  • Bacterial Vaginosis: A common vaginal infection caused by an imbalance of naturally occurring bacteria in the vagina.
  • Acne Vulgaris: A long-term skin condition characterized by the appearance of pimples, blackheads, and whiteheads, typically on the face, chest, and back.
  • Glioblastoma: An aggressive type of cancer that occurs in the brain or spinal cord.
  • Tumor Treating Fields (TTFields): A type of cancer treatment that uses electric fields to disrupt cell division in tumor cells.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Bioequivalence: The absence of a significant difference in the rate and extent to which the active ingredient becomes available at the site of drug action.
  • Topical: Applied directly to a part of the body, typically the skin.
  • Intravenous (IV): Administered directly into a vein.
  • Placebo: A substance with no active therapeutic effect, used as a control in testing new drugs.
  • Body Mass Index (BMI): A measure that uses your height and weight to work out if your weight is healthy.

References

  1. https://clinicaltrials.gov/study/NCT01744730
  2. https://clinicaltrials.gov/study/NCT01500837
  3. https://clinicaltrials.gov/study/NCT02348463
  4. https://clinicaltrials.gov/study/NCT04321070
  5. https://clinicaltrials.gov/study/NCT02593383
  6. https://clinicaltrials.gov/study/NCT04469075